Ulrich Roelcke

Aarau, AG, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.

Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.

Journal: Neuro-oncology practice
Published: March 18, 2024

Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.

Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.

Journal: Oncology
Published: May 10, 2022

Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.

Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.

Journal: Journal of neuro-oncology
Published: March 07, 2022

Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).

Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).

Journal: Swiss medical weekly
Published: May 17, 2021

A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.

A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.

Journal: Swiss medical weekly
Published: June 20, 2020

Long-term apparent diffusion coefficient value changes in patients undergoing radiosurgical treatment of meningiomas.

Long-term apparent diffusion coefficient value changes in patients undergoing radiosurgical treatment of meningiomas.

Journal: Acta neurochirurgica
Published: June 11, 2020

MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial.

MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 29, 2020

Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study.

Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study.

Journal: Swiss medical weekly
Published: December 05, 2019

Complementary and alternative medicine use by glioma patients in Switzerland.

Complementary and alternative medicine use by glioma patients in Switzerland.

Journal: Neuro-oncology practice
Published: August 07, 2019

Susceptibility and Tumor Size Changes During the Time Course of Standard Treatment in Recurrent Glioblastoma.

Susceptibility and Tumor Size Changes During the Time Course of Standard Treatment in Recurrent Glioblastoma.

Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging
Published: April 02, 2019

Spinal Metastases of Supratentorial Glioblastoma with Primitive Neuronal Component.

Spinal Metastases of Supratentorial Glioblastoma with Primitive Neuronal Component.

Journal: World neurosurgery: X
Published: December 14, 2018

Interictal epileptogenic zone localization in patients with focal epilepsy using electric source imaging and directed functional connectivity from low-density EEG.

Interictal epileptogenic zone localization in patients with focal epilepsy using electric source imaging and directed functional connectivity from low-density EEG.

Journal: Epilepsia open
Published: August 16, 2018
Showing 1-12 of 37

Last Updated: 09/26/2026